IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Checkpoint Capital L.P.

Q1 2025 Holdings

Filed 2025-05-15 | 14 holdings | $182.3M | 13F-HR | View on SEC ↗ · Holdings Table ↗

Sign in to see sub-manager breakdown

IssuerClassCUSIPValue ↓Shares% Portfolio
Argenx SE(ARGX)SPONSORED ADR04016X101$68.1M115,00037.3%
Rhythm Pharmaceuticals Inc(RYTM)COM76243J105$48.1M907,24026.4%
Revolution Medicines Inc(RVMD)COM76155X100$13.9M392,0117.6%
Soleno Therapeutics Inc(SLNO)COM834203309$12.4M172,9026.8%
Disc Medicine Inc(IRON)COM254604101$12.1M243,3116.6%
Protagonist Therapeutics Inc(PTGX)COM74366E102$8.5M175,1844.6%
Stoke Therapeutics Inc(STOK)COM86150R107$4.9M730,7172.7%
Septerna Inc(SEPN)COM81734D104$4.8M824,8782.6%
Kymera Therapeutics Inc(KYMR)COM501575104$3.7M136,6052.1%
Tscan Therapeutics Inc(TCRX)COM89854M101$2.8M2,017,6501.5%
Cidara Therapeutics Inc(CDTX)COM NEW171757206$2.2M104,3801.2%
Corcept Therapeutics Inc(CORT)COM218352102$571.1K5,0000.3%
Immunocore Hldgs PLC(IMCR)ADS45258D105$267.4K9,0110.1%
Rapt Therapeutics Inc(RAPTEUR)COM75382E109$134.0K109,8300.1%